|
1
|
Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.
|
Clin Infect Dis
|
2010
|
3.61
|
|
2
|
Bacterial meningitis in the United States, 1998-2007.
|
N Engl J Med
|
2011
|
2.99
|
|
3
|
Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.
|
Lancet Infect Dis
|
2012
|
2.74
|
|
4
|
Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.
|
Clin Infect Dis
|
2012
|
2.62
|
|
5
|
Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.
|
JAMA
|
2012
|
2.36
|
|
6
|
Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
|
MMWR Recomm Rep
|
2013
|
2.20
|
|
7
|
Detection of bacterial pathogens in Mongolia meningitis surveillance with a new real-time PCR assay to detect Haemophilus influenzae.
|
Int J Med Microbiol
|
2011
|
1.94
|
|
8
|
Early Impact of the US Tdap vaccination program on pertussis trends.
|
Arch Pediatr Adolesc Med
|
2012
|
1.69
|
|
9
|
Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
|
Clin Infect Dis
|
2008
|
1.60
|
|
10
|
Waning immunity to pertussis following 5 doses of DTaP.
|
Pediatrics
|
2013
|
1.58
|
|
11
|
Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America.
|
N Engl J Med
|
2009
|
1.48
|
|
12
|
sodC-based real-time PCR for detection of Neisseria meningitidis.
|
PLoS One
|
2011
|
1.45
|
|
13
|
Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States.
|
Vaccine
|
2011
|
1.40
|
|
14
|
Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogens.
|
J Clin Microbiol
|
2011
|
1.38
|
|
15
|
Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.
|
J Infect Dis
|
2010
|
1.31
|
|
16
|
Current epidemiology and trends in invasive Haemophilus influenzae disease--United States, 1989-2008.
|
Clin Infect Dis
|
2011
|
1.30
|
|
17
|
Global epidemiology of invasive meningococcal disease.
|
Popul Health Metr
|
2013
|
1.25
|
|
18
|
Cost analysis of an integrated disease surveillance and response system: case of Burkina Faso, Eritrea, and Mali.
|
Cost Eff Resour Alloc
|
2009
|
1.23
|
|
19
|
Neisseria meningitidis serogroup W, Burkina Faso, 2012.
|
Emerg Infect Dis
|
2014
|
1.22
|
|
20
|
Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.
|
Emerg Infect Dis
|
2014
|
1.17
|
|
21
|
Haemophilus haemolyticus isolates causing clinical disease.
|
J Clin Microbiol
|
2012
|
1.13
|
|
22
|
Pertussis control: time for something new?
|
Trends Microbiol
|
2012
|
1.08
|
|
23
|
Whole genome sequencing to investigate the emergence of clonal complex 23 Neisseria meningitidis serogroup Y disease in the United States.
|
PLoS One
|
2012
|
1.07
|
|
24
|
Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays.
|
Clin Vaccine Immunol
|
2011
|
1.06
|
|
25
|
Pertussis Pseudo-outbreak linked to specimens contaminated by Bordetella pertussis DNA From clinic surfaces.
|
Pediatrics
|
2012
|
1.01
|
|
26
|
Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005-2006.
|
Am J Trop Med Hyg
|
2009
|
0.98
|
|
27
|
Integrating host genomics with surveillance for invasive bacterial diseases.
|
Emerg Infect Dis
|
2008
|
0.95
|
|
28
|
Risk factors for meningococcal disease in students in grades 9-12.
|
Pediatr Infect Dis J
|
2008
|
0.93
|
|
29
|
Early estimate of the effectiveness of quadrivalent meningococcal conjugate vaccine.
|
Pediatr Infect Dis J
|
2011
|
0.91
|
|
30
|
Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States.
|
Clin Infect Dis
|
2013
|
0.88
|
|
31
|
Identifying host genetic risk factors in the context of public health surveillance for invasive pneumococcal disease.
|
PLoS One
|
2011
|
0.86
|
|
32
|
Genotypic comparison of invasive Neisseria meningitidis serogroup Y isolates from the United States, South Africa, and Israel, isolated from 1999 through 2002.
|
J Clin Microbiol
|
2009
|
0.83
|
|
33
|
Does tetanus-diphtheria-acellular pertussis vaccination interfere with serodiagnosis of pertussis infection?
|
Clin Vaccine Immunol
|
2012
|
0.83
|
|
34
|
Modeling insights into Haemophilus influenzae type b disease, transmission, and vaccine programs.
|
Emerg Infect Dis
|
2012
|
0.81
|
|
35
|
Haemophilus influenzae type b carriage among young children in metropolitan Atlanta in the context of vaccine shortage and booster dose deferral.
|
Clin Vaccine Immunol
|
2011
|
0.79
|
|
36
|
Inching toward a serogroup B meningococcal vaccine for infants.
|
JAMA
|
2012
|
0.77
|
|
37
|
Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women.
|
Emerg Infect Dis
|
2014
|
0.76
|
|
38
|
Estimating the effectiveness of acellular pertussis vaccines.
|
Clin Infect Dis
|
2012
|
0.75
|
|
39
|
Haemophilus influenzae type b disease and vaccine booster dose deferral, United States, 1998-2009.
|
Pediatrics
|
2012
|
0.75
|
|
40
|
MCV vaccination in the presence of vaccine-associated Guillain-Barré Syndrome risk: a decision analysis approach.
|
Vaccine
|
2009
|
0.75
|